Search Results - "HOFFKNECHT, M"

Early Recurrence or Persistence of Autoimmune Diseases After Unmanipulated Autologous Stem Cell Transplantation by Euler, Hans H., Marmont, Alberto M., Bacigalupo, Andrea, Fastenrath, Sven, Dreger, Peter, Hoffknecht, Matthias, Zander, Axel R., Schalke, Berthold, Hahn, Uwe, Haas, Rainer, Schmitz, Norbert

“…Autologous stem cell transplantation with or without in vitro lymphocyte depletion has been suggested as a new treatment option for severe autoimmune diseases…”
Get full text

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma by Hänel, M, Kröger, N, Sonnenberg, S, Bornhäuser, M, Krüger, W, Kroschinsky, F, Hänel, A, Metzner, B, Birkmann, J, Schmid, B, Hoffknecht, M M, Fiedler, F, Ehninger, G, Zander, A R

“…We investigated the efficacy and toxicity of the combination of busulfan, cyclophosphamide, and etoposide (Bu/Cy/VP-16) as a preparative regimen prior to…”
Get full text

Comparison between Bone Marrow and G‐CSF‐Mobilized Peripheral Blood Allografts Undergoing Clinical Scale CD34+ Cell Selection by Hassan, H. T., Zeller, W., Stockschläder, M., Krüger, W., Hoffknecht, M. M., Zander, A. R.

“…Allogeneic transplantation of selected CD34+ cells, rather than conventional transplantation of bone marrow (BM) harvest or peripheral blood (PB) leukapheresis…”
Get full text

Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy by KRÖGER, N, HOFFKNECHT, M, DREGER, P, KRÜGER, W, ZELLER, W, KRÜLL, A, STOCKSCHLÄDER, M, BITTNER, S, WEH, H. J, ZANDER, A. R

“…In advanced stage mantle cell lymphoma, conventional chemotherapy yields a complete remission rate below 40%, and the median survival rate is only about 3…”
Get full text

ASHAP: an effective salvage therapy for recurrent and refractory malignant lymphomas by HÄNEL, M, KRÖGER, N, KRÜGER, W. H, ZELLER, W, WEH, H, HOSSFELD, D. K, ZANDER, A. R, HOFFKNECHT, M. M, PETERS, S. O, METZNER, B, FIEDLER, F, BRAUMANN, D, SCHUBERT, J. C, ILLIGER, H. J, HÄNEL, A

“…This study was performed to examine the efficacy and toxicity of the combination of adriamycin (ADR), methylprednisolone (solumedrol), cytarabine (Ara-C), and…”
Get full text

Allogeneic bone marrow transplantation for refractory mantle cell lymphoma by KRÖGER, N, HOFFKNECHT, M, KRÜGER, W, ZELLER, W, RENGES, H, STUTE, N, ZSCHABER, R, ZANDER, A. R

“…We report about a 28-year-old woman with relapsed mantle cell lymphoma (MCL, centrocytic lymphoma according to the Kiel classification) refractory to salvage…”
Get full text

Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia by Stockschläder, M, Hegewisch-Becker, S, Krüger, W, tom Dieck, A, Mross, K, Hoffknecht, M, Berger, C, Kohlschütter, B, Martin, H, Peters, S

“…The outcome of 14 bone marrow transplants (BMT) (autologous 4; allogeneic 10) for Philadelphia-chromosome (Ph1) positive acute lymphoblastic leukemia (ALL) was…”
Get more information

Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy by KRÖGER, N, HOFFKNECHT, M, ZANDER, A. R, HÄNEL, M, KRÜGER, W, ZELLER, W, STOCKSCHLÄDER, M, DE WIT, M, WEH, H. J, KABISCH, H, ERTTMANN, R

“…Relapse after transplant for malignant lymphomas remains the main cause of treatment failure. Most conditioning regimens contain total body irradiation (TBI)…”
Get full text

Use of cryopreserved bone marrow in allogeneic bone marrow transplantation by Stockschläder, M, Krüger, W, Kroschke, G, Zeller, W, Hoffknecht, M, Löliger, C, Kabisch, H, Zander, A

“…Use of cryopreserved donor bone marrow may facilitate scheduling of allogeneic bone marrow transplantation (BMT) by affording independence of a fixed time for…”
Get more information

Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings : preliminary results by HORSTMANN, M, STOCKSCHLÄDER, M, KRÜGER, W, HOFFKNECHT, M, BETKER, R, KABISCH, H, ZANDER, A

“…Many approaches have been taken to reducing the rate of graft failure and the incidence of graft-versus-host disease (GVHD) in bone marrow transplantation…”
Get full text

Use of cryopreserved bone marrow in unrelated allogeneic transplantation by Stockschläder, M, Krüger, W, tom Dieck, A, Horstmann, M, Altnöder, M, Löliger, C, Fiedler, W, Hoffknecht, M, Erttmann, R, Zander, A

“…Cryopreservation of donor bone marrow can facilitate scheduling allogeneic bone marrow transplantation (BMT) by affording independence of a preset time for…”
Get more information

Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values by Krüger, W, Sobottka, I, Stockschläder, M, Mross, K, Hoffknecht, M, Rüssmann, B, Horstmann, M, Betker, R, Zander, A

“…Four patients undergoing allogeneic bone marrow transplantation were treated with liposomal (3 patients) and conventional (one patient) amphotericin-B for…”
Get more information

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer by Thomas, Michael, Prof, Rübe, Christian, Prof, Hoffknecht, Petra, MD, Macha, Hans N, Prof, Freitag, Lutz, MD, Linder, Albert, MD, Willich, Norman, Prof, Hamm, Michael, MD, Sybrecht, Gerhard W, Prof, Ukena, Dieter, Prof, Deppermann, Karl-Matthias, MD, Dröge, Cornelia, MD, Riesenbeck, Dorothea, MD, Heinecke, Achim, PhD, Sauerland, Cristina, MS, Junker, Klaus, Prof, Berdel, Wolfgang E, Prof, Semik, Michael, Prof

“…Summary Background Preoperative chemotherapy improves survival in patients with stage III non-small-cell lung cancer (NSCLC) amenable to resection. We aimed to…”
Get full text

Busulfan, cyclophosphamide, and etoposide e as high-dose conditioning regimen in patients with malignant lymphoma by HÄNEL, M, KRÖGER, N, HOFFKNECHT, M. M, FIEDLER, F, EHNINGER, G, ZANDER, A. R, SONNENBERG, S, BORNHÄUSER, M, KRÜGER, W, KROSCHINSKY, F, HÄNEL, A, METZNER, B, BIRKMANN, J, SCHMID, B

Get full text

Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation by Krüger, W, Stockschläder, M, Rüssmann, B, Berger, C, Hoffknecht, M, Sobottka, I, Kohlschütter, B, Kroschke, G, Kröger, N, Horstmann, M

“…60 patients undergoing bone marrow or stem cell transplantation were treated with liposomal Amphotericin-B for documented or suspected mycosis. 34 patients had…”
Get more information

754 5-FU/FA IV bolus therapy vs weekly high-dose 5-FU/FA 24-hour infusion in metastatic colorectal carcinoma: Preliminary results of an ongoing randomized phase III study by Weh, H.J., Hoffknecht, M., Hölzer, P., Braumann, D., Hoffman, R., Gellermann, H.J., Becker, K., Müllerleile, U., Drescher, S., Hossfeld, D.K.

“…Since January 1993 we are conducting a randomized phase III study in pts with metastatic colorectal carcinoma comparing 5-FU (425 mg/m 2)/FA (20 mg/m 2) days…”
Get full text

Neurotoxicity following weekly therapy with folinic acid and high-dose 5-fluorouracil 24-h infusion in patients with gastrointestinal malignancies by Weh, H J, Bittner, S, Hoffknecht, M, Hossfeld, D K

Get more information